This inventor holds 2 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignees: Denka Company Limited, Niigata University. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 388 
2 out of 73 
Years Active: 2022-2024
Title: The Innovative Mind of Yoshifumi Shimada: Advancements in Cancer Diagnosis
Introduction: Yoshifumi Shimada, an accomplished inventor based in Niigata, Japan, has made significant contributions to the field of cancer diagnosis through his notable patents. With a keen focus on leveraging technology to enhance medical accuracy, Shimada has developed innovative methods that promise to reshape the approach to hypermutated tumors.
Latest Patents: Among his two patents, the latest invention is a comprehensive system, program, and method for determining hypermutated cancerous tumors. This invention utilizes a sophisticated approach featuring an input unit capable of processing multiple image data types. The system distinguishes between pathological sections of hypermutated and non-hypermulted cancer with high accuracy. It employs machine learning to generate a determination model, ultimately allowing for improved accuracy in identifying whether a tumor is hypermutated based on newly inputted image data.
Career Highlights: Yoshifumi Shimada has built a notable career within significant institutions, including Niigata University and Denka Company Limited. His work in these reputable establishments has allowed him to engage in extensive research and development, facilitating innovations in medical technology and cancer diagnostics.
Collaborations: Throughout his career, Shimada has collaborated with esteemed colleagues such as Toshifumi Wakai and Shujiro Okuda. These partnerships have fostered an environment of shared knowledge and expertise, further advancing the quest for more effective cancer identification methodologies.
Conclusion: Yoshifumi Shimada stands out as a visionary inventor dedicated to improving cancer diagnosis through innovative technology. His contributions, particularly in the realm of hypermutated tumors, underscore the potential that inventions hold in revolutionizing medical practices. As he continues to develop and refine his techniques, the future of cancer diagnostics appears promising, driven by his unwavering commitment to innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile